Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Accumulated Expenses (2016 - 2025)

AC Immune (ACIU) has disclosed Accumulated Expenses for 10 consecutive years, with $10.1 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 26.91% to $10.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.1 million through Dec 2025, down 26.91% year-over-year, with the annual reading at $10.1 million for FY2025, 26.91% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $10.1 million at AC Immune, down from $13.8 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $18.2 million in Q4 2021, with the low at $9.8 million in Q4 2022.
  • Average Accumulated Expenses over 5 years is $12.9 million, with a median of $12.5 million recorded in 2023.
  • The sharpest move saw Accumulated Expenses soared 369.62% in 2021, then tumbled 46.14% in 2022.
  • Over 5 years, Accumulated Expenses stood at $18.2 million in 2021, then plummeted by 46.14% to $9.8 million in 2022, then increased by 27.87% to $12.5 million in 2023, then grew by 10.49% to $13.8 million in 2024, then fell by 26.91% to $10.1 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $10.1 million, $13.8 million, and $12.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.